One last launch for Pharmascience Canada this year

Pharmascience Canada is pleased to announce the launch of a new 100 tablet bottle format of pms-METHOTREXATE 2.5 mg tablets. The new 100 tablet format is in addition to our existing portfolio of 30 tablet blister packs. Both formats are now available for sale across Canada.

pms-METHOTREXATE belongs to a group of medication known as antimetabolites. It is indicated for Neoplastic diseases, such as :

  • Choriocarcinoma: Methotrexate – as single chemotherapy or in combination with other drugs.
  • Acute Lymphoblastic Leukemia – as maintenance therapy.
  • Head and Neck Cancer – in combination with other chemotherapies.
  • Metastasis of unknown primary – as palliative combination chemotherapy.
  • Burkitt’s lymphoma.
  • Advanced stages of childhood lymphoma (III and IV, St. Jude’s Childrens’ Research Hospital Staging System).
  • Advanced cases of mycosis fungoides (cutaneous T-cell lymphoma).

pms-METHOTREXATE is also indicated as a Disease Modifying Antirheumatic Drug (DMARD) in the following diseases where standard therapeutic interventions fail:

  • Severe disabling psoriasis/psoriatic arthritis
  • Severe disabling rheumatoid arthritis (RA)
  • Severe disabling seronegative arthritides.



Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries. Ranked 47th among Canada’s top 100 Research & Development (R&D) investors in 2020, with 40-50 million dollars invested each year, Pharmascience Inc. is among the largest drug manufacturers in Canada.

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal and professional development. In 2022, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People and named as one of Montreal’s best employers, as part of the Canada’s Top 100 Employers project. Pharmascience is now certified as a Great Place to Work.

For product information, please contact Pharmascience’s Medical Information Department at 1-888-550-6060.

Published in

Product Launches